This article is more than 5 years old. Information may no longer be current.

Bausch + Lomb requests extended wear for Ultra lenses

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Bausch + Lomb has filed a Premarket Approval Application with the FDA for its Ultra contact lenses for up to 7 days of extended wear

The company announced in a press release that it fielded a 1-year, randomized, masked, controlled trial at 34 sites in the U.S. to assess the safety and efficacy of the Ultra samfilcon A soft contact lens for wear up to 7 days. These results have been submitted to the FDA.

“As patient care is our primary focus, it is important to provide eye care professionals another option to meet the unique lifestyle needs of their patients,” John Ferris, vice president and general manager at U.S. Vision Care at Bausch + Lomb, said in the release. “We believe Bausch + Lomb Ultra contact lenses deliver on these needs and are supported by clinical research to support the [Premarket Approval Application].”

Ultra contact lenses are also available for patients with astigmatism and presbyopia.